RedShift BioAnalytics
Total Raised
$90.01MInvestors Count
12Deal Terms
5Funding, Valuation & Revenue
12 Fundings
RedShift BioAnalytics has raised $90.01M over 12 rounds.
RedShift BioAnalytics's latest funding round was a Series F - II for $5.91M on June 25, 2025.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/25/2025 | Series F - II | $5.91M | 1 | |||
4/2/2024 | Series F | $5M | 1 | |||
10/18/2021 | Series E | $20M | 3 | |||
12/23/2020 | Series D - II | |||||
4/12/2020 | Loan |
Date | 6/25/2025 | 4/2/2024 | 10/18/2021 | 12/23/2020 | 4/12/2020 |
|---|---|---|---|---|---|
Round | Series F - II | Series F | Series E | Series D - II | Loan |
Amount | $5.91M | $5M | $20M | ||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 | 1 | 3 |
RedShift BioAnalytics Deal Terms
5 Deal Terms
RedShift BioAnalytics's deal structure is available for 5 funding rounds, including their Series C from March 14, 2017.
Round | Series C | Unattributed | Series B | Series A - II | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series C | |||||||||||||||
Unattributed | |||||||||||||||
Series B | |||||||||||||||
Series A - II | |||||||||||||||
Series A |
RedShift BioAnalytics Investors
12 Investors
RedShift BioAnalytics has 12 investors. Technology Venture Partners invested in RedShift BioAnalytics's Series F - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/23/2006 | 6/25/2025 | 9 Series A, Series A - II (2009), Series B (2013), Series C (2017), Series D (2018), Series D - II (2020), Series E (2021), Series F (2024), Series F - II (2025) | Venture Capital | Minnesota | ||
10/18/2021 | 6/25/2025 | 2 Series E, Series F - II (2025) | Venture Capital | California | ||
4/2/2024 | 6/25/2025 | 2 Series F, Series F - II (2025) | Venture Capital | Minnesota | ||
Corporation | Massachusetts | |||||
Venture Capital | Ohio |
First funding | 1/23/2006 | 10/18/2021 | 4/2/2024 | ||
|---|---|---|---|---|---|
Last Funding | 6/25/2025 | 6/25/2025 | 6/25/2025 | ||
Investor | |||||
Rounds | 9 Series A, Series A - II (2009), Series B (2013), Series C (2017), Series D (2018), Series D - II (2020), Series E (2021), Series F (2024), Series F - II (2025) | 2 Series E, Series F - II (2025) | 2 Series F, Series F - II (2025) | ||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Corporation | Venture Capital |
Location | Minnesota | California | Minnesota | Massachusetts | Ohio |
Compare RedShift BioAnalytics to Competitors
Applied Isotope Technologies provides measurement solutions for elemental, speciated, and molecular analysis across various sectors. The services offered include biomarker analysis, environmental toxin detection, food and supplement analysis, fossil fuel testing, neuropeptide quantification, and exposomics research. The company serves sectors requiring precise and legally defensible data for research and regulatory purposes. It was founded in 2003 and is based in Pittsburgh, Pennsylvania.

Evolutionary Genomics operates in the biotechnology sector, focusing on plant genetic enhancement. The company develops and patents genes that confer resistance to pests and diseases, enhance sweetness, and improve yield in various crops. It was founded in 2000 and is based in Longmont, Colorado.
Solecta specializes in membrane separation solutions within the industrial sector. The company offers polymeric membranes for microfiltration, ultrafiltration, nanofiltration, and reverse osmosis. Solecta primarily serves sectors such as food, dairy, life sciences, and manufacturing industries. It was founded in 1998 and is based in Oceanside, California.
Nano Carrier is a biotech company using nanotechnology to improve patient Quality of Life with a focus on cancer.
J. Lamarck is a company that offers advisory services to private individuals, companies and pension funds who want to invest in the biotechnology sector.nThe company offers a high quality service and its analyst provide professional assistance to people who want to diversify a part of their portfolio in this emerging industry. Because of the nature of biotechnology investments, the company believe it is important that users work with specialists to define their portfolio strategy. Generally, specialists do things better.nOver the next few years the company will be witness of astonishing progress in health care and medicine, the company will be able to fight and cure diseases like AIDS and cancer finally. The company will also find solutions to clean up the environment and new crops that don't need pesticide. These new products will obviously boost the visibility of the companies that were at the beginning of this process on the stock market and consequently create great opportunity for it's shareholders.nJ. Lamarck wants to be their partner in this great venture.

Fluidic Analytics conducts protein interaction analysis and biomolecular characterization within the life sciences sector. The company provides tools and technologies for measuring protein interactions and characteristics in solution, related to drug discovery and disease diagnosis. Fluidic Analytics serves sectors engaged in biological research and clinical diagnostics. It was founded in 2013 and is based in Royston, England.
Loading...

